CVS Sells Epinephrine Auto-Injector For 80 Percent Less Than EpiPen

By John Wilkerson / February 22, 2017 at 6:27 PM
CVS Health is selling an EpiPen substitute for $110, 80 percent cheaper than EpiPen, CVS President and CEO Larry Merlo said during a recent investor call. That price is available to anyone, regardless of whether they're insured. EpiPen is the latest drug to make headlines for drastic price hikes , and it set the stage for brand drug makers to blame pharmacy benefit managers for taking a large cut of profits in the form of rebates. Heather Bresch, the CEO...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.